
Closed
Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022
R&D partnering mission for Canadian SMEs
Record updated
- Funding available
- Varies by project
- Deadline
- Unspecified
- Location
- Canada
Overview
Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 was open to small and medium-sized enterprises seeking personalized medicine partnering opportunities in Germany. Technologies of interest included biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA, and CRISPR.
At a glance
Funding available
Varies by project
- Develop strategic partnerships
- Conduct research and development activities
- Access new markets
Eligible candidates
- Location
- Canada
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- All groups
- Legal structures
- All legal structures
Receipt of requests is now closed
Get notified about updates to this grant.
Availability timeline
2023
Periods: 1
Eligibility
Who is eligible?
- Small and medium-sized enterprises
Additional information
- The page is archived and will not be updated.
- Technologies and products of particular interest include biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, advanced therapies such as cell and gene therapies, CAR-T cells and tissue engineered therapies, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA and CRISPR.
Official sources
Frequently Asked Questions about the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 Program
What is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?
Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 was open to small and medium-sized enterprises seeking personalized medicine partnering opportunities in Germany. Technologies of interest included biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA, and CRISPR.
Who is eligible for the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program?
To be eligible for the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program, you must:
Small and medium-sized enterprises
Who can I contact for more information about the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?
You can contact National Research Council Canada (NRC).
Where is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 available?
The Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program is available across Canada.
Is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 a grant, loan, or tax credit?
Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 is a Partnering and Collaboration
Who are the financial supporters of the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?
Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 is funded by National Research Council Canada (NRC)
